Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutchs pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nations first cancer prevention research program, as well as the clinical coordinating center of the Womens Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employeeswho bringdifferent and innovativeways of seeing the world and solving problems.Fred Hutch is in pursuit of becoming an antiracist organization.Weare committed to ensuring that all candidates hired share our commitment to diversity,antiracism, and inclusion.
The HIV Vaccine Trials Network (HVTN) is the worlds largest publicly funded multi-disciplinary international collaboration facilitating the development of vaccines to prevent HIV/AIDS. The HVTN conducts all phases of clinical trials, from evaluating experimental vaccines for safety and immunogenicity to testing vaccine efficacy and is housed at the Fred Hutchinson Cancer Research Center (Fred Hutch). The COVID-19 Prevention Network (CoVPN) was formed by the National Institute of Allergy and Infectious Diseases (NIAID) at the US National Institutes of Health to respond to the global pandemic. Using the infectious disease expertise of their existing research networks and global partners, NIAID has directed the networks to address the pressing need for vaccines and monoclonal antibodies (mAbs) against SARS-CoV-2.
The Clinical Trials Physician plays a key role in providing scientific and clinical oversight and project management for the development and implementation of HIV vaccine and monoclonal antibody trials. We are looking for a physician with active interest in early phase trials who will work with the NIH and other developers in translating preclinical to clinical development. Clinical trials physicians report directly to HVTN leadership. Some experience with early phase trials; knowledge of preclinical toxicity models is desirable but not mandatory.
In collaboration with Network Principal Investigators and CoVPN and HVTN leadership, provide scientific review and input into concept and protocol development
Manage multidisciplinary teams and institutions organized around the development and implementation of HIV and SARS-CoV-2 vaccine and monoclonal antibody protocols
Represent the Network in interactions with Principal Investigators, vaccine developers, and other vaccine research and public health organizations involved in HIV and SARS-CoV-2 vaccine discovery
Contribute to a core capacity for review and summary of scientific literature and analysis related to key issues for trial design
Manage timelines for protocol development and implementation, to assure timely start dates for clinical trials. This includes process development and manufacturing of novel products
Participate in the review of safety data from all phases of vaccine and monoclonal antibody clinical trials; this includes providing clinical input into the design of clinical monitoring plans and serving as medical monitor for clinical trials
Other duties as assigned
A physician (M.D. or equivalent degree) is required
Preference will be given to those applicants with experience in clinical trials and to those applicants with training in phase 1 or preclinical evaluations of vaccines or antibodies
Board certification in internal medicine, family practice, pediatrics, preventive medicine, or infectious disease is desirable
The ideal candidate should:
be highly organized
have exceptional written and verbal communication skills
have experience managing multidisciplinary teams
be able to handle challenging workloads and multiple concurrent projects
be proficient with standard business productivity software, including word processing, spreadsheet, presentation graphics, and database applications
A statement describing your commitment and contributions toward greater diversity, equity, inclusion, and antiracism in your career or that will be made through work at Fred Hutch is requested of all finalists.
Our Commitment to Diversity
We are proud to be an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at firstname.lastname@example.org or by calling 206-667-4700.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.